Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Applied Therapeutics, Inc. | Chief Operating Officer and Chief Business Officer | Common Stock | 621K | $273K | $0.44 | Mar 24, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
APLT | Applied Therapeutics, Inc. | Mar 24, 2025 | 1 | $0 | 4 | Mar 26, 2025 | Chief Operating Officer and Chief Business Officer |
APLT | Applied Therapeutics, Inc. | Mar 4, 2025 | 1 | -$197 | 4 | Mar 6, 2025 | Chief Operating Officer and Chief Business Officer |
APLT | Applied Therapeutics, Inc. | Feb 6, 2025 | 1 | -$17.2K | 4 | Feb 7, 2025 | Chief Operating Officer and Chief Business Officer |
APLT | Applied Therapeutics, Inc. | Dec 28, 2023 | 1 | $0 | 4 | Mar 18, 2024 | Chief Operating Officer and Chief Business Officer |
APLT | Applied Therapeutics, Inc. | Dec 28, 2023 | 0 | $0 | 3 | Mar 18, 2024 | Exhibit 24.1 -- Power of Attorney Chief Operating Officer and Chief Business Officer |